DMII (Drugs Made In America Acquisition II) OCF Yield %: -0.17 (As of Jul. 11, 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II OCF Yield %?

Drugs Made In America Acquisition II DMII 15 OCF Yield % is -0.17 as of Jul. 11, 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 559 Diversified Financial Services companies, Drugs Made In America Acquisition II ranks better than 62.61% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Drugs Made In America Acquisition II's Trailing 12-Month Cash Flow from Operations is $-1.11 Mil, and Market Cap is $643.37 Mil. Therefore, Drugs Made In America Acquisition II's OCF Yield % for today is -0.17%.

The historical rank and industry rank for Drugs Made In America Acquisition II's OCF Yield % or its related term are showing as below:

DMII' s OCF Yield % Range Over the Past 10 Years
Min: -0.17   Med: 0   Max: -0.17
Current: -0.17

During the past 2 years, the highest OCF Yield % of Drugs Made In America Acquisition II was -0.17%. The lowest was -0.17%. And the median was %.

DMII's OCF Yield % is ranked better than
62.61% of 559 companies
in the Diversified Financial Services industry
Industry Median: -0.33 vs DMII: -0.17

Drugs Made In America Acquisition II's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Drugs Made In America Acquisition II OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Drugs Made In America Acquisition II OCF Yield % Related Terms

Drugs Made In America Acquisition II OCF Yield % Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II OCF Yield % Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
OCF Yield %
0.00 -0.16

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial 0.00 0.00 0.00 -0.20 -0.06

DMII vs BCSS, EVAC, CEPF: OCF Yield % Comparison

For the Shell Companies subindustry, Drugs Made In America Acquisition II's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Drugs Made In America Acquisition II OCF Yield % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Drugs Made In America Acquisition II's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Drugs Made In America Acquisition II's OCF Yield % falls into.


DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Drugs Made In America Acquisition II's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-1.018 / 630.63
=-0.16%

Drugs Made In America Acquisition II's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.103 * 4 / 635.089
=-0.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -0.17 mean?
Drugs Made In America Acquisition II (DMII) has a OCF Yield % of -0.17 as of Jul. 11, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Drugs Made In America Acquisition II and its competitors. According to the industry distribution chart, Drugs Made In America Acquisition II ranks #209 out of 559 companies in the Diversified Financial Services industry, placing it in the top 37.4%.
Is Drugs Made In America Acquisition II's OCF Yield % too high?
Drugs Made In America Acquisition II's current OCF Yield % is -0.17. Based on the distribution chart, Drugs Made In America Acquisition II ranks #209 out of 559 companies in the Diversified Financial Services industry, which is above the industry midpoint. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's OCF Yield % compare to BCSS and EVAC?
According to the Diversified Financial Services industry distribution chart, Drugs Made In America Acquisition II ranks #209 out of 559 companies for OCF Yield %. This puts Drugs Made In America Acquisition II in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Diversified Financial Services company?
A good OCF Yield % depends on the Diversified Financial Services industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current OCF Yield % is -0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current OCF Yield % of -0.17. The current OCF Yield % is -0.17. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current OCF Yield % is -0.17 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price